Skip to main content
. 2014 Aug 12;12:213. doi: 10.1186/s12967-014-0213-2

Figure 4.

Figure 4

Vector plots of SP-triggered PGD 2 and pLT dynamics derived from PBLs of MCAS and SM patients and healthy controls. Origin of arrows: basal eicosanoid release; arrowheads: SP-triggered eicosanoid release; grey arrows: control, healthy individuals (n = 20); black arrows: MCAD-M, MCAD patients without MCAD-specific medication (n = 9); red arrows: MCAD + M, MCAD patients with MCAD-specific medication (n = 13); black numbers: patients’ identification numbers (see Table 1) (A) MCAS: MCAD patients with mast cell activation syndrome (n = 12); (B) SM: MCAD patients with systemic mastocytosis (n = 10).